News for hackers. Stuff that matters.
Re:Covid-19 Vaccination-Associated Myocarditis in Adolescent... by kafkaIncarnate on Monday August 23, 2021 @03:17AM (#28273072)
> All were doing well clinically with resolution of their symptoms in most. Seven patients (13%) reported non-specific symptoms including intermittent atypical chest pain (4), palpitations (2) and mild fatigue with minimal activity (1). All patients had normal ventricular function, based on echocardiography. The 4 patients who had presented with arrhythmias earlier continue to be in normal sinus rhythm with no recurrence.

> Follow up CMR studies have been scheduled and are pending at the time of this submission for rest of the patients. There were no acute events, re- hospitalization or deaths reported.

> Although myocarditis following immunizations against smallpox, influenza, and tetanus is well recognized, 13-16 the experience in children with vaccine associated myocarditis, other than following COVID-19 vaccination is limited. Importantly, myocarditis was not reported following the clinical trials of mRNA COVID-19 vaccines.17,18 This may be related to the limited number of patients in the clinical trials and reflective of the apparent rarity of this complication.19

> The present study adds the following information to our understanding of myocarditis related to the COVID-19 vaccine: 1. Myocarditis following mRNA vaccines is associated with acute myocardial injury and edema of the myocardium, in the presence of preserved ventricular function. 2. The initial clinical course and short-term outcomes are good and reassuring. 3. There is no apparent difference in clinical characteristics and outcomes between 12–15- year-olds and older adolescents. 4. The clinical picture is distinct from multisystem inflammatory syndrome in children (MIS- C) and appears to be less severe.

> Limitations of our study include its retrospective nature, combining patients from 16 different institutions which used similar, but not identical approaches during the work-up and management of childhood myocarditis. Our cases represent a selected cohort which may not necessarily be representative of the general pediatric population.

Also, preprint despite being through peer-review might change their conclusions based on the fact that the discussion section conflicts, low N values, etc.

Seems less of a problem than the blood-clots, though should be something doctors be aware of while vaccinating children to be certain it isn't happening. Looks like it's being treated successfully and heals appropriately, though, with existing medicine.

There are no comments on this comment yet.